Most Active Stories
- Fresno County Seeks to Eliminate Health Safety Net for the Undocumented
- Centennial Corridor Freeway Project Divides Bakersfield, Neighborhood
- Fresno Mayor Ashley Swearengin Announces State Controller Run
- Caltrans Picks Preferred Route For Centennial Corridor Freeway in Bakersfield
- In California, Researchers Uncertain If Drought Will Increase Valley Fever Risk
Valley Public Radio Staff
Mon April 1, 2013
Novartis Loses Patent Battle In India
Originally published on Fri April 5, 2013 5:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.